---
title: "ContraFect Corporation (CFRXQ.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CFRXQ.US.md"
symbol: "CFRXQ.US"
name: "ContraFect Corporation"
industry: "生物技术"
---

# ContraFect Corporation (CFRXQ.US)

| Item | Detail |
|------|--------|
| Industry | 生物技术 |
| Location | 美股市场 |
| Website | [www.contrafect.com](https://www.contrafect.com) |

## Company Profile

ContraFect Corp.是一家临床阶段的生物技术公司，专注于发现和开发直接溶解剂（DLAs），包括溶菌酶和阿莫林肽，用于治疗威胁生命的耐药性感染的新医疗模式。其产品流水线包括 CF-301、革兰阴性溶菌酶和阿莫林肽。该公司由罗伯特·诺文斯基于2008年3月5日创立，总部位于纽约州的扬克斯市。

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/CFRXQ.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CFRXQ.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CFRXQ.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.